Showing results (1281-1290 of 1,487) with videos related to
Sort By:
Pageof 149
Plos One|March 2, 2017
The salivary microbiome is altered in the presence of a high salivary glucose concentrationJ Max Goodson, Mor-Li Hartman, Ping Shi, et al.Vaccine|March 25, 2019
Accelerating measles and rubella elimination through research and innovation - Findings from the Measles & Rubella Initiative research prioritization process, 2016Gavin B Grant, Balcha G Masresha, William J Moss, et al.ACS Biomaterials Science & Engineering|October 5, 2022
Evaluation of Human Performance Aiding Live Synthetically Engineered Bacteria in a Gut-on-a-ChipM Tyler Nelson, Heidi G Coia, Corey Holt, et al.JCI Insight|August 23, 2022
FGF21 controls hepatic lipid metabolism via sex-dependent interorgan crosstalkAki T Chaffin, Karlton R Larson, Kuei-Pin Huang, et al.Plos One|September 30, 2015
Continuous Metabolic Syndrome Scores for Children Using Salivary BiomarkersPing Shi, J Max Goodson, Mor-Li Hartman, et al.Molecules (Basel, Switzerland)|February 11, 2023
Hyperpolarizing DNA Nucleobases via NMR Signal Amplification by Reversible ExchangeBryce E Kidd, Max E Gemeinhardt, Jamil A Mashni, et al.Small (Weinheim an Der Bergstrasse, Germany)|March 23, 2026
Mesoporous Silica Nanoparticles-Based Formulations for Enhanced Oral Delivery of Peptide Drugs: A Case Study on InsulinClaudia Iriarte-Mesa, Estelle Juère, Andrea Bileck, et al.Vaccine|February 1, 2015
Serogroup A meningococcal conjugate (PsA-TT) vaccine coverage and measles vaccine coverage in Burkina Faso--implications for introduction of PsA-TT into the Expanded Programme on ImmunizationSarah A Meyer, Jean Ludovic Kambou, Amanda Cohn, et al.Vaccine|March 23, 2019
Research priorities for accelerating progress toward measles and rubella elimination identified by a cross-sectional web-based surveyJennifer L Kriss, Gavin B Grant, William J Moss, et al.The Journal of Biological Chemistry|March 2, 2005
Complete inhibition of anisomycin and UV radiation but not cytokine induced JNK and p38 activation by an aryl-substituted dihydropyrrolopyrazole quinoline and mixed lineage kinase 7 small interfering RNAXushan Wang, Mary M Mader, John E Toth, et al.Pageof 149